Novavax Asks EU Regulator to Clear COVID Vaccine for Teens

March 31, 2022

(Associated Press) – The pharmaceutical developer Novavax says it has asked the European Medicines Agency to extend the authorization of its coronavirus vaccine to children aged 12 to 17 amid a surge of disease across the continent. (Read More)